Calcimedica, Common Stock Stock Market Value
| CALC Stock | 2.74 0.04 1.44% |
| Symbol | CalciMedica, |
CalciMedica, Common Stock Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.11) | Return On Assets (0.65) | Return On Equity (0.84) |
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CalciMedica, Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CalciMedica, Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CalciMedica, Common.
| 11/19/2024 |
| 12/19/2024 |
If you would invest 0.00 in CalciMedica, Common on November 19, 2024 and sell it all today you would earn a total of 0.00 from holding CalciMedica, Common Stock or generate 0.0% return on investment in CalciMedica, Common over 30 days. CalciMedica, Common is related to or competes with Willamette Valley, Fevertree Drinks, Stepan, Anheuser Busch, Thai Beverage, Keurig Dr, and Codexis. CalciMedica, Common is entity of United States More
CalciMedica, Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CalciMedica, Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CalciMedica, Common Stock upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 45.05 | |||
| Value At Risk | (7.66) | |||
| Potential Upside | 4.72 |
CalciMedica, Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CalciMedica, Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CalciMedica, Common's standard deviation. In reality, there are many statistical measures that can use CalciMedica, Common historical prices to predict the future CalciMedica, Common's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.37) |
CalciMedica, Common Stock Backtested Returns
CalciMedica, Common Stock secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. CalciMedica, Common Stock exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CalciMedica, Common's Standard Deviation of 5.7, mean deviation of 3.31, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.06, which signifies a somewhat significant risk relative to the market. CalciMedica, Common returns are very sensitive to returns on the market. As the market goes up or down, CalciMedica, Common is expected to follow. At this point, CalciMedica, Common Stock has a negative expected return of -0.82%. Please make sure to confirm CalciMedica, Common's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if CalciMedica, Common Stock performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.20 |
Weak predictability
CalciMedica, Common Stock has weak predictability. Overlapping area represents the amount of predictability between CalciMedica, Common time series from 19th of November 2024 to 4th of December 2024 and 4th of December 2024 to 19th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CalciMedica, Common Stock price movement. The serial correlation of 0.2 indicates that over 20.0% of current CalciMedica, Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
CalciMedica, Common Stock lagged returns against current returns
Autocorrelation, which is CalciMedica, Common stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CalciMedica, Common's stock expected returns. We can calculate the autocorrelation of CalciMedica, Common returns to help us make a trade decision. For example, suppose you find that CalciMedica, Common has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CalciMedica, Common regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CalciMedica, Common stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CalciMedica, Common stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CalciMedica, Common stock over time.
Current vs Lagged Prices |
| Timeline |
CalciMedica, Common Lagged Returns
When evaluating CalciMedica, Common's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CalciMedica, Common stock have on its future price. CalciMedica, Common autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CalciMedica, Common autocorrelation shows the relationship between CalciMedica, Common stock current value and its past values and can show if there is a momentum factor associated with investing in CalciMedica, Common Stock.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:Check out CalciMedica, Common Correlation, CalciMedica, Common Volatility and CalciMedica, Common Alpha and Beta module to complement your research on CalciMedica, Common. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
CalciMedica, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.